Preliminary unpublished results from our laboratory showed increased phosphorylated SMAD1/5/9 and decreased multidrug resistance gene 1 (MDR1) expression, in pediatric glioblastoma KNS42 cells harboring an H3F3A G34V mutation, following BMP4 treatment. This evidence concerns the gene BMP4 and glioblastoma.